Prostate Cancer

Enzalutamide in biochemically recurrent prostate cancer: design and rationale of the EMBARK study. March 26, 2025

Evaluating the prognostic significance of artificial intelligence-delineated gross tumor volume and prostate volume measurements for prostate radiotherapy. March 26, 2025

Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model. March 26, 2025

The landscape of N6-methyladenosine in localized primary prostate cancer. March 26, 2025

Quality of Care and Survival Outcomes Among Patients With Clinically Localized Prostate Cancer in Nigeria. March 26, 2025

Radical prostatectomy is associated with favorable outcomes in patients over 80 years old. March 26, 2025

Role of region-of-interest magnetic resonance imaging fusion biopsy in mitigating overtreatment of localized prostate cancer - A retrospective cohort study. March 25, 2025

Altered vertebral biomechanical properties in prostate cancer patients following androgen deprivation therapy. March 25, 2025

Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study. March 25, 2025

Diagnostic performance of high-resolution micro-ultrasound and conventional ultrasound in fusion biopsy for clinically significant prostate cancer detection. March 25, 2025

Does inclusion of neighborhood variables improve clinical risk prediction for advanced prostate cancer in Black and White men? March 25, 2025

Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada. March 25, 2025

Understanding the hospital safety net: Hospital resource limitations impact prostate cancer treatment beyond socioeconomic disparities. March 24, 2025

Small-molecule RNA therapeutics to target prostate cancer. March 24, 2025

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium. March 24, 2025

Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPC. March 24, 2025

Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. March 24, 2025

FDA Approves New Prostate Cancer Imaging Agent Gozellix® March 21, 2025

Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort. March 21, 2025

Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe. March 21, 2025

Page 1 of 1466